Chimeric Hla-antigen Receptor (char) T-cell Engineering-a New Approach to Target Hla Sensitization

I. Gille; M. Vergunst; E. Van der Meer-Prins; S. Heidt; I. Gille; R. Hagedoorn; M. Heemskerk

Chimeric Hla-antigen Receptor (char) T-cell Engineering-a New Approach to Target Hla Sensitization

I. Gille
, M. Vergunst
, E. Van der Meer-Prins
, S. Heidt
, I. Gille
, R. Hagedoorn
, M. Heemskerk

Leiden University

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

Original language	English
Pages (from-to)	26-26
Number of pages	1
Journal	Human Immunology
Volume	83
Publication status	Published - Nov 2022
Externally published	Yes
Event	48th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics (ASHI) - Las Vegas Duration: 24 Oct 2022 → 28 Oct 2022

Cite this

@article{66e37311bc58481ba23f3106d5296cf8,

title = "Chimeric Hla-antigen Receptor (char) T-cell Engineering-a New Approach to Target Hla Sensitization",

author = "I. Gille and M. Vergunst and \{Van der Meer-Prins\}, E. and S. Heidt and I. Gille and R. Hagedoorn and M. Heemskerk",

year = "2022",

month = nov,

language = "English",

volume = "83",

pages = "26--26",

journal = "Human Immunology",

issn = "0198-8859",

publisher = "Elsevier Inc.",

note = "48th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics (ASHI) ; Conference date: 24-10-2022 Through 28-10-2022",

}

TY - JOUR

T1 - Chimeric Hla-antigen Receptor (char) T-cell Engineering-a New Approach to Target Hla Sensitization

AU - Gille, I.

AU - Vergunst, M.

AU - Van der Meer-Prins, E.

AU - Heidt, S.

AU - Gille, I.

AU - Hagedoorn, R.

AU - Heemskerk, M.

PY - 2022/11

Y1 - 2022/11

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000891281900015&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0198-8859

VL - 83

SP - 26

EP - 26

JO - Human Immunology

JF - Human Immunology

T2 - 48th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics (ASHI)

Y2 - 24 October 2022 through 28 October 2022

ER -

Chimeric Hla-antigen Receptor (char) T-cell Engineering-a New Approach to Target Hla Sensitization

Other files and links

Cite this